. Author manuscript; available in PMC: 2011 Jun 20.

Published in final edited form as: Clin Cancer Res. 2009 Feb 17;15(5):1534–1542. doi: 10.1158/1078-0432.CCR-08-1783

Table 1.

Frequency of lymphoma, myeloproliferation and other malignancies

		Lymphoma	Myelopro- liferation	Other Malignancies^*	Myeloid Hyperplasia
1	WT Control	0/20(0)	0/20(0)	0/20(0)	0/20(0)
2	NQO2-Null Control	5/20(25)	0/20(0)	0/20(0)	18/20(90)
3		P<0.0281	P<0.9999	P<0.9999	P<0.0001
4	WT 1Gy	0/20(0)	0/20(0)	0/20(0)	0/20(0)
5	NQO2-Null 1Gy	8/19(42)	5/19(26)	6/19(32)	19/20(95)
6		P<0.0002	P<0.0001	P<0.0001	P<0.0001
7	WT 3Gy	2/19(11)	0/19(0)	0/19(0)	0/20(0)
8	NQO2-Null 3Gy	13/18(72)	4/18(22)	3/18(17)	18/20(90)
9		P<0.0001	P<0.0001	P<0.0205	P<0.0001

Most other malignancies were lung adenocarcinoma.

Numbers in parenthesis show the percentage of mice with lymphoma, myeloproliferation, other malignancies, and myeloid hyperplasia.

The experiments were setup in four groups and each group contained 5 animals. P values for WT and NQO2-Null control are shown in line 3. P values for WT 1Gy versus NQO2-Null 1Gy are shown in line 6. P values for WT 3Gy versus NQO2-Null are shown in line 9.